Chronic albumin infusions to achieve diuresis in patients with ascites who are not candidates for transjugular intrahepatic portosystemic shunt (TIPS)

Digestive Diseases and Sciences

Volumn 50, Issue 7, 2005, Pages 1356-1360

  Trotter, J ^a   Pieramici, E ^a   Everson, G T ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Albumin; Ascites; Cirrhosis; Diuretics; Transjugular intrahepatic portosystemic shunt (TIPS)

Indexed keywords

ALBUMIN; BILIRUBIN; FUROSEMIDE; SPIRONOLACTONE; ALBUMINOID;

ADULT; ARTICLE; ASCITES; BIOCHEMISTRY; BODY WEIGHT; BRAIN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIURESIS; FEMALE; HEMATOCRIT; HUMAN; HYPERBILIRUBINEMIA; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER FAILURE; MALE; OUTPATIENT; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; TREATMENT CONTRAINDICATION; UREA NITROGEN BLOOD LEVEL; WEIGHT REDUCTION; DRUG ADMINISTRATION; DRUG CONTRAINDICATION; DRUG EFFECT; HISTORY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

ALBUMINS; ASCITES; DIURESIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HISTORY, 20TH CENTURY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RETROSPECTIVE STUDIES;

EID: 23044488881     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2787-2     Document Type: Article

References (14)

1. Gines P, Cardenas A, Arroyo V, Rodes J: Management of cirrhosis and ascites. N Engl J Med 350:1646-1654, 2004
2. Moore KP, Wong F, Gines P, et al.: The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 38:258-266, 2003
3. Janeway CA, Gibson ST, Woodruff LM, Heyl JT, Bailey GT, Newhouser LR:. Chemical, clinical and immunological studies on the products of human plasma fractionation: concentrated human serum albumin. J Clin Invest 23:465-191, 1944
4. Faloon WN, Echkardt RD, Murphy TL, Cooper AM, Davidson CS: An evaluation of human serum albumin in the treatment of cirrhosis of the liver. J Clin Invest 28:583-594, 1949
5. Havens WP, Bluemle LW: The effect of human serum albumin and mercurial diuretics on ascites in patients with hepatic cirrhosis. Gastroenterology 16:455-474, 1950
6. Patek AJ, Mankin H, Colcher H, Lowell A, Earle DP: The effects of intravenous infection of concentrated human serum albumin upon blood plasma, ascites and renal function in three patients with cirrhosis of the liver. J Clin Invest 27:135-145, 1948
7. Kunkel HG, Labby DH, Ahrens EH, Shank RE, Hoagland CL: The use of concentrated human serum albumin in the treatment of cirrhosis of the liver. J Clin Invest 27:305-320, 1948
8. Watson CJ, Greenberg A: Certain effects of salt poor human albumin in cases of hepatic disease. Am J Med Sci 217:651-657, 1949
9. Dykes PW: A study of the effects of albumin infusions in patients with cirrhosis of the liver. Q J Med 30:297-327, 1961
10. Thorn GW, Armstrong SH, Davenport VD: Chemical, clinical, and immunological studies on the products of human plasma fractionation. XXXI. The use of salt-poor concentrated human serum albumin solution in the treatment of hepatic cirrhosis. J Clin Invest 25:304-323, 1946
11. Post J, Rose JV, Shore SM: Intravenous use of salt-poor human albumin. Arch Intern Med 87:775-788, 1954
12. Schindler C, Ramadori G: Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and refractory ascites. J Hepatol 31:1132, 1999
13. Gentilini P, Casini-Raggi V, DiFiore GD, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 30:639-645, 1999
14. Blendis L, Wong F: Intravenous albumin with diuretics: protean lesions to be learnt? J Hepatol 30:727-730, 1999